Evidence map›Paper›PMID 41136809›Full record

ArticleJournal of computer-aided molecular design2025

In vitro and in silico evaluation of synthesized 4-Anilinoquinazoline derivatives as potential anticancer agents.

Yusuf Eka Maulana, Ade Danova, Chanat Aonbangkhen, Jaruwan Chatwichien, Sutthida Wongsuwan, Elvira Hermawati, Warinthorn Chavasiri, Anita Alni

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yusuf Eka MaulanaOrganic Chemistry Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Jl. Ganesha 10, Bandung, 40132, West Java, Indonesia.
Ade DanovaOrganic Chemistry Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Jl. Ganesha 10, Bandung, 40132, West Java, Indonesia.
Chanat AonbangkhenCenter of Excellence in Natural Products Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand.
Jaruwan ChatwichienProgram in Chemical Sciences, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
Sutthida WongsuwanCenter of Excellence in Natural Products Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand.
Elvira HermawatiOrganic Chemistry Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Jl. Ganesha 10, Bandung, 40132, West Java, Indonesia.
Warinthorn ChavasiriCenter of Excellence in Natural Products Chemistry, Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand.
Anita AlniOrganic Chemistry Division, Faculty of Mathematics and Natural Sciences, Institut Teknologi Bandung, Jl. Ganesha 10, Bandung, 40132, West Java, Indonesia. alni@itb.ac.id.

Funding

ITB research grant No. 959/IT1.B07.1/TA.00/2024NRIIS project number 4790478
6 · The paper itself

Abstract

Twenty-three 4-anilinoquinazoline derivatives were successfully synthesized, including six new compounds (8, 9, 12, 17, 19, 20) and seventeen known compounds. Seventeen derivatives (10-26) were evaluated for cytotoxic activity against three cancer cell lines (A549, HepG2, and SH-SY5Y) using the MTT assay. The results showed that compound 13 exhibited high selectivity toward the SH-SY5Y cell line with an IC

Indexed as

Aniline CompoundsAntineoplastic AgentsQuinazolinesCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorHep G2 CellsHumansHydrogen BondingMolecular Docking SimulationMolecular Dynamics SimulationStructure-Activity RelationshipAniline CompoundsanilinoquinazolineAntineoplastic AgentsQuinazolines4-anilinoquinazolineAnticancerin silico evaluationin vitro

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.